Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TBC1D8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SERBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPATCH11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCL3P4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1033 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MANEA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGFR1OP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM87B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on